Takeda Pharmaceutical Co Ltd (TAK)
Takeda to Hold Earnings Call for Fiscal Year 2025 3rd Quarter on January 29
Takeda to Hold Earnings Call for Fiscal Year 2025 3rd Quarter on January 29
Notification of cessation of securities - MSB
Notification regarding unquoted securities - MSB
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
Managing Director’s letter to shareholders
ResMed Inc. Daily Stock Update
Notification from cbdMD, Inc.
Biomerica, Inc. - Biomerica Reports Second Quarter Fiscal 2026 Financial Results
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
Notification from BriaCell Therapeutics Corp.